Alnylam Pharmace. buy klostergang
Start price
01.10.19
/
50%
€71.64
Target price
04.11.21
€150.00
Performance (%)
96.54%
End price
17.06.21
€140.80
Summary
This prediction ended on 17.06.21 with a price of €140.80. With a performance of 96.54% the BUY prediction by klostergang was a big success. klostergang has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -0.362% | -0.362% | 23.564% | 60.263% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% | 51.204% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% | 93.733% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% | 51.187% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% | 65.291% |
Comments by klostergang for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy mit Kursziel 130,0
Kursziel geändert auf 140,0
Kursziel geändert auf 150,0